Back to Search
Start Over
Dendreon Statement on CMS National Coverage Analysis
- Source :
- Drug Week. July 16, 2010, 159
- Publication Year :
- 2010
-
Abstract
- Dendreon Corporation (NASDAQ: DNDN) announced that the Centers for Medicare and Medicaid Services (CMS) today initiated a National Coverage Analysis (NCA) of PROVENGE® (sipuleucel-T), an autologous cellular immunotherapy for the [...]
Details
- Language :
- English
- ISSN :
- 15316440
- Database :
- Gale General OneFile
- Journal :
- Drug Week
- Publication Type :
- News
- Accession number :
- edsgcl.231230199